Hims and Hers beats revenue estimates on strong subscriber growth - TradingView

Reuters | Nov. 3, 2025, 4:24 p.m. | Original
Hims and Hers beats revenue estimates on strong subscriber growth TradingView
Sarepta's Duchenne gene therapy misses main goal in study - TradingView Sarepta's Duchenne gene therapy misses main goal in late-stage study; shares fall - TradingView